Obermatt

LifeMD

NMQ:LFMD · US53216B1044
Health Care TechnologySmall

360

78
Profit price13
Owner Earnings Yield68
Dividend Yield1
Price/Sales88
EV / Gross Profit95
Price/Book5
Return on Capital5
Cash Return on Capital100
Return on Equity4
EBIT Margin33
Gross Profitability100
Cash Conversion36
Accruals77
Owner Earnings Margin68
Sales growth64
Profit Growth43
Long-Term EPS Growth76
Reinvestment27
Price momentum10
Debt load52
Refinancing3
Debt Payback100
Liquidity19
Analyst ratings100
Opinion Changes50
Price Target Upside98
Market mood60
Value Creation16/20strong value creator
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

LifeMD generates returns well above its cost of capital, the foundation of durable shareholder value.

Profile

CountryUSA
IndustryHealth Care Technology
SizeSmall
TypePublic Company
ExchangeNASDAQGM
Founded1994
Employees183
Websitelifemd.com
ISINUS53216B1044
Last UpdateApr 2, 2026
Themes
MHealthWomen's HealthHealth DiagnosticsDigital WellnessDigital Mental HealthHealth Care

Description

LifeMD, Inc. (LifeMD), a direct-to-patient healthcare company, provides a way for patients to access virtual medical care and pharmacy services. Through the company’s vertically integrated care model, the company combines proprietary technology, aff…

Analysis

Middle-of-the-road

LifeMD, Inc. is a middle-of-the-road business: neither the economics nor the price stand out from the peer group.

The price is expensive. You pay 48.0× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 18% yearly growth; analysts expect 13%. The gap between price and consensus is worth watching: demanding expectations.

The trajectory is moderate and the balance sheet is sturdy. The company scores 16/20 on our value-creation score: strong value creator.

Nothing is flagged here: no red or amber gates, no divergence between profits and cash. That is itself information: the numbers are straightforward. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
6
2023202420252026

All-time high

91

Jan 2023

All-time low

6

Jun 2026

Average rank

53

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
88
59
51
96
Price/Earnings
10
4
35
35
Price/Book
5
100
97
96
Dividend Yield
1
1
1
1
Value (overall)
12
76
70
93

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare LifeMD with its peers
American Well
NYQ:AMWL
36
CountryUSA
IndustryHealth Care Technology
SizeSmall
Full Stock Analysis →
Jamieson Wellness
TOR:JWEL
38
CountryCanada
IndustryPersonal Products
SizeMedium
Full Stock Analysis →
Pfizer Limited
NSI:PFIZER
65
CountryUSA
IndustryPharmaceuticals
SizeMedium
Full Stock Analysis →
Phreesia
NYQ:PHR
70
CountryUSA
IndustryHealth Care Technology
SizeMedium
Full Stock Analysis →
Cybin
NEO:HELP
CountryCanada
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Alumis
NSQ:ALMS
22
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →